• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ASSURANT COBALT; STENT, ILIAC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ASSURANT COBALT; STENT, ILIAC Back to Search Results
Device Problems Fracture (1260); Positioning Problem (3009); Migration (4003)
Patient Problem Unspecified Tissue Injury (4559)
Event Date 06/02/2020
Event Type  Injury  
Manufacturer Narrative
Journal title: bare stents for iliac chronic total occlusions (¿¿telis¿¿): a prospective cohort study with a midterm follow-up doi: 10.1016/j.Avsg.2020.05.046.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A journal article was submitted detailing a study to assess primary bare stenting for iliac chronic total occlusions (ctos) with midterm follow-up.46 patients with 49 iliac ctos treated were included in the study.Medtronic¿s assurant cobalt and everflex stents were implanted.The technical success rate was 98%.One technical failure occurred because of impossible cia occlusion¿s crossing both by crossover and brachial access.No surgical conversion was observed.Four extended dissections of downward segment to the lesion were observed (2 eia and 2 cia) and successfully treated by adjunctive stenting.Two closure devices (non-medtronic) failures and 3 minor hematomas were observed.One complication not related to the procedure occurred (hyperkalemia with arrhythmia).6 non-procedural related deaths were reported in the population at 2 years.Other outcomes at 2 years include three major cardiovascular events were reported, 2 strokes and 1 myocardial ischemia.No major amputation was noted.Three thrombosis were observed (1 at 1 month and 2 at 2 years).Tlr was performed by open surgery with iliofemoral thrombectomy and cross-femoral bypass for 2 patients.One patient had a redo surgery for stent migration which was treated endovascularly by cia kissing-stent procedure.Three stent fractures were noted, one type 1 located at the cia level and two type 2 at the eia level.None of those fractures led to symptoms, restenosis, thrombosis, or reintervention.There is no established or suspected causal relationship between the device(s) and the death events.
 
Manufacturer Narrative
This report is being submitted as part of a retrospective review and remediation for capa 564121 per d00916038.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ASSURANT COBALT
Type of Device
STENT, ILIAC
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key11796431
MDR Text Key249671274
Report Number9612164-2021-01827
Device Sequence Number1
Product Code NIO
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P110011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/10/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/06/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age59 YR
Patient SexMale
-
-